Tyra Biosciences prices $400 million equity offering to fund dabogratinib development and other programs
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
HK retail sales could rise by 8.4pc in 2026: Deloitte
Accounting giant Deloitte on Monday raised its full-year forecast for the city's retail sales to a growth of 8.4 percent year on year to HK$412 billion in 2026.
Ringgit ends lower against US dollar, higher against major peers
Rising Brent crude prices add to inflationary pressures as markets await the Federal Open Market Committee and Bank of Japan rate decisions, says analyst.
Ringgit ends lower against US dollar, higher against major peers
Rising Brent crude prices add to inflationary pressures as markets await the Federal Open Market Committee and Bank of Japan rate decisions, says analyst.
Lemonade's Loss Ratio Improved to 60%, and Its Gross Profit Rose 76%. The Stock Is Still 49% Off Its High.
Is it a buy on the dip or a value trap?
